DIMENSIONAL FUND ADVISORS LP

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 354204 AUSTIN, TX

Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$55,942,563

+$16,848,521 QoQ

Shares Held

874,786

+7.7% QoQ

Ownership

0.561%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#11

of 266 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 90% Shared 5% None 4%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $3,170,376,127 across 48 Drug Manufacturers - Specialty & Generic names. KNSA ranks #15 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	25,417,271	$625,519,037
2	VTRS	Viatris Inc	29,970,094	$475,925,092
3	UTHR	UNITED THERAPEUTICS Corp	527,904	$286,034,221
4	ALKS	Alkermes plc.	4,194,873	$219,811,343
5	LNTH	Lantheus Holdings, Inc.	1,466,260	$162,666,882
6	ZTS	Zoetis Inc.	2,173,278	$156,171,754
7	PBH	Prestige Consumer Healthcare Inc.	2,661,291	$125,799,224
8	NBIX	Neurocrine Biosciences Inc	732,877	$123,519,088

All Filings in KNSA

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$55,942,563	874,786	+7.7%	Shares	Sole	2026-08-11
2026-03-31	$39,094,042	811,922	+18.8%	Shares	Sole	2026-05-07
2025-12-31	$28,194,580	683,505	+8.1%	Shares	Sole	2026-02-12
2025-09-30	$24,545,334	632,123	-2.5%	Shares	Sole	2025-11-12
2025-06-30	$17,939,455	648,336	-16.1%	Shares	Sole	2025-08-12
2025-03-31	$17,152,848	772,303	+0.1%	Shares	Sole	2025-05-13
2024-12-31	$15,262,384	771,607	+3.9%	Shares	Sole	2025-02-13
2024-09-30	$18,550,249	742,307	+11.8%	Shares	Sole	2024-11-07
2024-06-30	$12,397,624	664,040	—	Shares	Sole	2024-08-09
No filing history on record for this holder in this stock.